considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD.

B BE‘QHL DRUGS LIMITED Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INDORE-452016 (M.P.) INDIA Tel, 0731) 2517677 | E-mail : beryldrugs25@yahoo.com | CIN : L02423MP1993PLC007840 s 2z oz - S = e Date: 29.09.2026 The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai — 400001 Subject: Approval for Increase in the Limit of Material Related Party Transactions with M/s. Aminova Infusions Pvt. Ltd. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule Il of the Securities and Exchange Board of India (Listing tO hb al ti g ta ht ei o Mn es ma bn ed D si s oc fl o ts hu er e oR me pq au nir ye ,m e atn t ts h) 3Re 3g "u l Aa nt ni uon as l, G2 e0 n1 e5 ( l“ S ME eB eI L ii ns gti n (g ARe Gg Mu ”l )a t hi eo lns d” o), w 2e h Ser ee pb ty mi bn ef ro ,r m 0y 2o 6u at 11:00 A.M. and concluded at 11:30 A.M. have approved the following resolution as an Ordinary Resolution: Approval for increase in the limit of material related party transactions with M/s. Aminova Infusions Put. Ltd. The Members have approved the revision of the aggregate maximum value of material related party transactions with M/s. Aminova Infusions Pvt. Ltd. (“Aminova”) from X5.00 crore to %8.00 crore, during the unexpired period of the existing approval granted by the Members at the EGM held on 11th May, 2026. The revised limit of X8.00 crore shall constitute the overall ceiling for the transactions covered under the existing approval during the originally approved tenure of two years and shall not be construed as an additional X8.00 crore limit over and above the transactions already undertaken pursuant to the earlier approval. Except for the aforesaid increase in the aggregate maximum monetary limit, all other terms and conditions, cn oa nt tu ir ne eo f ot r ra en ms aa ict ni o inn s f, rt ce en fu or re ha en d rio gt ih nae lr yp aa pr pa rm oe vt ee dr s eo rf ot dh .e earlier approval shall remain unchanged and The transactions with Aminova shall continue to be undertaken in the ordinary course of business and on an arm's length basis and shall remain subject to the applicable provisions of the Companies Act, 2013, SEBI Listing Regulations and the Company's Related Party Transactions Policy. pT rh ee cv ro it bi en dg tr ie ms eu ll it ns so .f the AGM, along with the Scrutinizer's Report, will be submitted separately within the This is for your information and records. Thanking you, For Beryl Drugs Limited Sudhir Sethi Chairman& Direct DIN: 00090172